MYRIAD GENETICS INC (MYGN)
US62855J1043 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -263.30M | -112.00M | -27.20M | -199.50M | 4.60M | |||
| Depreciation Amortization | 61.90M | 52.70M | 62.80M | 72.00M | 73.00M | |||
| Income Taxes - Deferred | -4.00M | -30.80M | -32.10M | -55.80M | 18.60M | |||
| Change In Working Capital | 10.70M | -101.50M | 120.40M | 115.10M | -37.10M | |||
| Interest Paid | 1.40M | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 1.90M | 1.80M | -85.40M | 1.00M | 6.50M | |||
| Other non cash items | 83.80M | 85.30M | -105.70M | 128.90M | 24.60M | |||
| OPERATING CASH FLOW | -110.90M | -106.30M | 18.20M | 60.70M | 83.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -73.30M | -45.30M | -18.00M | -10.20M | -8.60M | |||
| Other Investing Activity | 105.20M | -32.20M | 292.40M | 29.50M | -277.80M | |||
| INVESTING CASH FLOW | 31.90M | -77.50M | 274.40M | 19.30M | -286.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 39.80M | 0.00 | -226.40M | -8.60M | 225.00M | |||
| Stock Issued/Repurchased | 114.80M | -4.30M | 80.30M | 3.50M | -41.30M | |||
| Other Financing Activity | -1.70M | -3.70M | -4.50M | -4.90M | -1.40M | |||
| FINANCING CASH FLOW | 152.90M | -8.00M | -150.60M | -10.00M | 182.30M | |||
| Exchange Rate Effect | 600.00K | -600.00K | -600.00K | 500.00K | 2.70M | |||
| CHANGE IN CASH | 74.50M | -192.40M | 141.40M | 70.50M | -17.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -110.90M | -106.30M | 18.20M | 60.70M | 83.70M | |||
| Capital Expenditure | -73.30M | -45.30M | -18.00M | -10.20M | -8.60M | |||
| FREE CASH FLOW | -184.20M | -151.60M | 200.00K | 50.50M | 75.10M | |||
All data in USD